DuraTerra is building a patent-pending microbial delivery platform, engineered as a foundation that can extend across broadacre agriculture, livestock, native landscapes and mine site rehabilitation.
Biological products are one of agriculture's fastest-growing categories, but commercial adoption has often lagged the science — because the microbes that perform in a lab frequently don't survive the journey into a working paddock. DuraTerra's core IP is the delivery architecture itself: an organic, low-emission granule engineered to carry a live, multi-species microbial consortium intact to the root zone.
That's a platform bet, not a single-crop bet. The same delivery architecture is designed to extend across cropping, grazing, native soils and rehabilitation land — building an evidence base market by market rather than claiming it all at once.
The multi-layer coating and delivery architecture is the subject of an active patent filing.
Field-trial work is in progress at a Western Australian broadacre site, with further replicated trials planned. results published as validated
DuraTerra is also developing a carbon-insetting approach, built on measured soil-carbon improvement rather than purchased offsets. program in development
We're not selling a fertiliser. We're building the delivery layer biology has always needed.Mark Riseley, Founder & Managing Director, DuraTerra
We welcome enquiries from sophisticated and wholesale investors. Get in touch and select "Investment enquiry" — we'll follow up directly.
This page is general information only and does not constitute financial product advice or an offer of securities. It has been prepared without taking into account the objectives, financial situation or needs of any individual. Any prospective investor should seek their own legal, financial and taxation advice before making an investment decision. Further information is available directly from DuraTerra to eligible investors on request.